FORMULATION A LIBERATION LENTE COMPRENANT ESTRADIOL ET PROGESTERONE

• 收藏
• 分享

专利权人:

SKENDI FINANCE; LTD.

发明人:

申请号：

EP04736545.7

公开号：

EP1663161B1

申请日:

2004.06.10

申请国别(地区):

EP

年份:

2015

代理人:

摘要：

The invention provides a method for effecting simultaneous contraception and hormone replacement therapy in a female mammal comprising administering to said mammal a pharmaceutical formulation comprising particles of 17-²-estradiol and cholesterol in about a 1:1 molar ratio, and particles of progesterone； wherein the weight ratio of 17-²-estradiol to progesterone is about 1:40.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/